Global Malaria Diagnostics Market Study Analysis: Surge In Healthcare Expenditure Globally Will Boost The Growth Of Market

The Global Malaria Diagnostics Market was estimated to be $ Billion in 2028 and is anticipated to grow at a CAGR of more than 6.87% from 2021 to 2028. Malaria is a mosquito-borne infectious life-threatening disease caused by parasites. The mosquito bite leads to the transfer of single-cell microorganisms of the plasmodium group into a human body. There are five species of plasmodium that are Plasmodium falciparum, Plasmodium malaria, Plasmodium ovale, and Plasmodium knowlesi. The Plasmodium falciparum causes the greatest number of deaths. When infected mosquito bites parasites are lodged into the liver and matures. These parasites after some time moves to bloodstreams start infecting red blood cells. They grow inside the blood cells and kill them this stage is known as merozoites. Malaria infected person experiences fever, tiredness, vomiting, and headache, and in some serious cases it also leads to yellow skin, seizures, coma, or death. According to the WHO malaria report 2019, In 2018, there were 405,000 deaths globally compared with 416, 000 estimated deaths in 2017, and 585, 000 in 2010. The rising prevalence of the disease and technological advancements in the field of malaria diagnostics is expected to drive the malaria diagnostics global market growth.

To request a free sample, Go To: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006877

Global Malaria Diagnostics Drivers And Restrain:
The major factors that have impacted the growth of malaria diagnostics are increasing government initiatives for the diagnosis and treatment of malaria, technological advancement, and others.

Increasing Government Initiatives:
Government investments to curb disease is expected to drive the malaria diagnostics market growth. There are many initiatives and programs such as Clinton Health Access Initiative, President’s Malaria Initiatives, Population Services International. According to WHO’s World Malaria Report 2019, in 2018, approximately US$ 2.7 billion was invested in malaria control and elimination by governments of malaria-endemic countries and international partners. The international funders invested US$ 1.8 billion for malaria control in the endemic countries whereas and the governments of the endemic countries contributed 30% of the total funding that is US$ 900 million. The increasing awareness among public and government initiatives to suppress malaria is projected to fuel the malaria diagnostics market growth.

Technological Advancement:
The continuous innovations in technology have encouraged the adaptation of more advanced technology for the diagnosis of malaria. The advanced technology would be helpful for the early and precise diagnosis of malaria. Moreover, the advanced technology is adopted for malaria diagnostics to offer a pocket-friendly diagnosis for the public is also projected to drive propel the malaria diagnostics market growth.
The market may be hampered by low demand in underdeveloped countries.

Impact Of COVID-19 on the Malaria Diagnostics Market:
• Impact on Market Size
• End-User Trend, Preferences, and Budget Impact
• Regulatory Framework/Government Policies
• Key Players Strategy to Tackle Negative Impact
• Opportunity Window

Global Malaria Diagnostics Market Segments:
The global Malaria Diagnostics market is further segmented into technology, end-users, and geography.
By Technology: Rapid Diagnostics Test, Microscopy, Molecular Diagnostics Test, and Clinical Diagnostics
By End User: Hospitals, Clinics, and Community Healthcare

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa and South America)

Asia-Pacific region is estimated to show prominence in the Malaria Diagnostics market attributed to the increasing in the number of patients, growing geriatric population, rising awareness, and increasing high funding from governments. Furthermore, in developing economies, the growing demand for advanced technologies, increase in disposable income are anticipated to fuel the market growth. and Europe is also expected to show lucrative growth in the malaria diagnostics market due to increased cases brought by migrants and tourists coming to this region. North America region is also expected to drive the market attributed to increased funding for malaria diagnosis by the government and private organizations.

Key Players of Global Malaria Diagnostics Market:
• Abbott Laboratories
• Access Bio Inc
• Atlas Medical
• Biomérieux
• Bio-Rad Laboratories Inc
• Meridian Bioscience Inc
• Novartis
• Olympus Corporation
• Premier Medical Corporation Pvt Ltd
• Siemens AG

For Any Query or Customization, Ask Our Industry Experts@https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=006877

Key Questioned Answered Through The Report:
• The Impact of COVID-19 on the global market
• What are the potential opportunities for new entrants in the global market
• What is the market Size and Forecast from 2020 to 2028?
• Key Players associated with the global Malaria Diagnostics Market
• Value Chain Analysis of Global Malaria Diagnostics Market
• What is the CAGR of the Global Malaria Diagnostics Market from 2021 to 2028
• Major Growth Factor, Challenges, Trends, and Opportunities in the global market
• Key outcomes of SWOT Analysis

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advising service that offers creative solutions to a company's problems. Data beneficial to micro, small, medium, and large-scale businesses can be found in our market research studies. We offer a wide range of services, from data collection to business consulting.
Evolve Business Intelligence is built on account of technology advancement and our in-house AI-modelled data analysis and forecast tool – EvolveBI – provides extremely accurate data. This application tracks real-time statistics from Fortune's Global 2000 firms, including quarterly performance, annual performance, and recent changes.

This release was published on openPR.